Summary of Study ST001268
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000853. The data can be accessed directly via it's Project DOI: 10.21228/M8F108 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST001268 |
Study Title | Metabolome data to annotate metabolite origins |
Study Summary | Plasma metabolomics from HIV subjects and controls was incorporated with microbiome data to develop Annotation of Metabolite Origins via Networks (AMON). |
Institute | University of Colorado Denver |
Department | Anschutz Medical Campus |
Last Name | Reisdorph |
First Name | Nichole |
Address | 12850 East Montview Blvd, Aurora, CO, 80045, USA |
nichole.reisdorph@ucdenver.edu | |
Phone | 3037249234 |
Submit Date | 2019-10-22 |
Total Subjects | 63 |
Raw Data Available | Yes |
Raw Data File Type(s) | d |
Analysis Type Detail | LC-MS |
Release Date | 2019-10-11 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000853 |
Project DOI: | doi: 10.21228/M8F108 |
Project Title: | Integrating microbiome and metabolome data to annotate metabolite origins |
Project Summary: | Untargeted metabolomics of host-associated samples has yielded insights into mechanisms by which microbes modulate health. However, data interpretation is challenged by the complexity of origins of the small molecules measured, which can come from the host, microbes that live within the host, or from other exposures such as diet or the environment. We address this challenge through development of AMON: Annotation of Metabolite Origins via Networks. AMON is an open-source bioinformatics application that can be used to annotate which compounds in the metabolome could have been produced by bacteria present or the host, to evaluate pathway enrichment of host verses microbial metabolites, and to visualize which compounds may have been produced by host versus microbial enzymes in KEGG pathway maps. |
Institute: | University of Colorado Denver |
Department: | Anschutz Medical Campus |
Last Name: | Reisdorph |
First Name: | Nichole |
Address: | 12850 East Montview Blvd, Aurora, CO, 80045, USA |
Email: | nichole.reisdorph@ucdenver.edu |
Phone: | 3037249234 |
Funding Source: | NIH |
Subject:
Subject ID: | SU001336 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Gender: | Male and female |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | HIV |
---|---|---|
SA092075 | GLD066 | Negative |
SA092076 | GLD065 | Negative |
SA092077 | GLD045 | Negative |
SA092078 | GLD018 | Negative |
SA092079 | GLD017 | Negative |
SA092080 | GLD063 | Negative |
SA092081 | GLD062 | Negative |
SA092082 | GLD051 | Negative |
SA092083 | GLD056 | Negative |
SA092084 | GLD060 | Negative |
SA092085 | GLD061 | Negative |
SA092086 | GLD070 | Negative |
SA092087 | GLD071 | Negative |
SA092088 | GLD048 | Negative |
SA092089 | GLD074 | Negative |
SA092090 | GLD046 | Negative |
SA092091 | GLD002 | Negative |
SA092092 | GLD032 | Negative |
SA092093 | GLD008 | Negative |
SA092094 | GLD012 | Negative |
SA092095 | GLD049 | Negative |
SA092096 | GLD011 | Negative |
SA092097 | GLD013 | Negative |
SA092098 | GLD010 | Negative |
SA092099 | GLD053 | Positive |
SA092100 | GLD047 | Positive |
SA092101 | GLD050 | Positive |
SA092102 | GLD069 | Positive |
SA092103 | GLD079 | Positive |
SA092104 | GLD080 | Positive |
SA092105 | GLD073 | Positive |
SA092106 | GLD072 | Positive |
SA092107 | GLD055 | Positive |
SA092108 | GLD057 | Positive |
SA092109 | GLD054 | Positive |
SA092110 | GLD039 | Positive |
SA092111 | GLD019 | Positive |
SA092112 | GLD016 | Positive |
SA092113 | GLD020 | Positive |
SA092114 | GLD021 | Positive |
SA092115 | GLD022 | Positive |
SA092116 | GLD014 | Positive |
SA092117 | GLD009 | Positive |
SA092118 | GLD004 | Positive |
SA092119 | GLD003 | Positive |
SA092120 | GLD005 | Positive |
SA092121 | GLD006 | Positive |
SA092122 | GLD007 | Positive |
SA092123 | GLD023 | Positive |
SA092124 | GLD026 | Positive |
SA092125 | GLD040 | Positive |
SA092126 | GLD001 | Positive |
SA092127 | GLD041 | Positive |
SA092128 | GLD042 | Positive |
SA092129 | GLD043 | Positive |
SA092130 | GLD037 | Positive |
SA092131 | GLD036 | Positive |
SA092132 | GLD028 | Positive |
SA092133 | GLD027 | Positive |
SA092134 | GLD029 | Positive |
SA092135 | GLD030 | Positive |
SA092136 | GLD031 | Positive |
SA092137 | GLD044 | Positive |
Showing results 1 to 63 of 63 |
Collection:
Collection ID: | CO001330 |
Collection Summary: | During a clinic visit, blood was drawn from HIV positive individuals and controls as previously described as part of a larger study of differences in the fecal microbiome in HIV positive and high risk populations [Caporaso JG, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335–6. doi:10.1038/nmeth.f.303]. |
Sample Type: | Blood (plasma) |
Storage Conditions: | -80℃ |
Treatment:
Treatment ID: | TR001351 |
Treatment Summary: | Three cohorts based on HIV status: (1) HIV-1 infection untreated; (2) chronic HIV-1 infection on long-term ART; (3) healthy controls (HIV-negative individuals both high and low risk for contracting HIV). |
Sample Preparation:
Sampleprep ID: | SP001344 |
Sampleprep Summary: | 100 µL of plasma spiked with internal standards underwent a protein crash with 400 µL ice cold methanol. The supernatant was dried under nitrogen. Methyl tert-butyl ether (MTBE) and water were added to extract the hydrophobic and hydrophilic compounds, respectively. The upper hydrophobic layer was transferred to a new tube and the lower hydrophilic layer was re-extracted with MTBE. The upper hydrophobic layer was combined, dried under nitrogen and reconstituted in 200 µL of methanol. The hydrophilic layer was dried under nitrogen, underwent a second protein crash with water and ice-cold methanol (1:4 water-methanol). The supernatant was removed, dried by SpeedVac at 45 °C and reconstituted in 100 µL of 5% acetonitrile in water. Both fractions were stored at -80 °C until LCMS analysis. |
Processing Storage Conditions: | On ice |
Combined analysis:
Analysis ID | AN002105 | AN002106 | AN002107 | AN002108 |
---|---|---|---|---|
Analysis type | MS | MS | MS | MS |
Chromatography type | Reversed phase | Reversed phase | HILIC | HILIC |
Chromatography system | Agilent 1290 | Agilent 1290 | Agilent 1290 | Agilent 1290 |
Column | Agilent Zorbax RRHD SB-C18 (100 x 2.1mm,1.8um) | Agilent Zorbax RRHD SB-C18 (100 x 2.1mm,1.8um) | Phenomenex Kinetex HILIC 100A (50 x 2.1 mm,2.6um) | Phenomenex Kinetex HILIC 100A (50 x 2.1 mm,2.6um) |
MS Type | ESI | ESI | ESI | ESI |
MS instrument type | QTOF | QTOF | QTOF | QTOF |
MS instrument name | Agilent 6520 QTOF | Agilent 6520 QTOF | Agilent 6550 QTOF | Agilent 6550 QTOF |
Ion Mode | POSITIVE | NEGATIVE | POSITIVE | NEGATIVE |
Units | Abundance | Abundance | Abundance | Abundance |
Chromatography:
Chromatography ID: | CH001537 |
Chromatography Summary: | Gradient was as follows: 0–1 minutes 30–70% B, 1–7.92 minutes 70–100% B, 7.92–10.4 minutes 100% B, 10.4–10.5 minutes 100–30% B, 10.5–15.1 minutes 30% B. |
Instrument Name: | Agilent 1290 |
Column Name: | Agilent Zorbax RRHD SB-C18 (100 x 2.1mm,1.8um) |
Column Temperature: | 60 °C |
Flow Rate: | 0.7 mL/min |
Injection Temperature: | 4 °C |
Solvent A: | 100% water; 0.1% formic acid |
Solvent B: | 60% isopropanol/36% acetonitrile/4% water; 0.1% formic acid |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH001538 |
Chromatography Summary: | Gradient elution was as follows: 0–2 minutes 100% B, 2–2.1 minutes 100–90% B, 2.1–8.6 minutes 90–50% B, 8.6–8.7 minutes 50–0% B, 8.7–14.7 minutes 0% B, 14.7–14.8 minutes 0–100% B, 14.8–24.8 minutes 100% B. |
Instrument Name: | Agilent 1290 |
Column Name: | Phenomenex Kinetex HILIC 100A (50 x 2.1 mm,2.6um) |
Column Temperature: | 20 °C |
Flow Rate: | 0.6 mL/min |
Injection Temperature: | 4 °C |
Solvent A: | 50% acetonitrile/50% water; ammonium acetate, pH 5.8 |
Solvent B: | 90% acetonitrile/10% water; pH 5.8 ammonium acetate |
Chromatography Type: | HILIC |
MS:
MS ID: | MS001956 |
Analysis ID: | AN002105 |
Instrument Name: | Agilent 6520 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Scan range 50-1700 m/z, scan rate 2.2 spectra/sec, gas temp 300C, gas flow 12 L/min, nebulizer 30 psig, Vcap 4000 V, fragmentor 120 V. Data processed with Profinder B.08 using small molecule chromatographic extraction. |
Ion Mode: | POSITIVE |
MS ID: | MS001957 |
Analysis ID: | AN002106 |
Instrument Name: | Agilent 6520 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Scan range 50-1700 m/z, scan rate 1.0 spectra/sec, gas temp 300C, gas flow 12 L/min, nebulizer 30 psig, Vcap 4000 V, fragmentor 120 V. Data processed with Profinder B.08 using small molecule chromatographic extraction. |
Ion Mode: | NEGATIVE |
MS ID: | MS001958 |
Analysis ID: | AN002107 |
Instrument Name: | Agilent 6550 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Scan range 75-1700 m/z, scan rate 2.0 spectra/sec, gas temp 225C, gas flow 18 L/min, nebulizer 45 psig, Vcap 3500 V, fragmentor 360 V. Data processed with Profinder B.08 using small molecule chromatographic extraction. |
Ion Mode: | POSITIVE |
MS ID: | MS001959 |
Analysis ID: | AN002108 |
Instrument Name: | Agilent 6550 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Scan range 75-1700 m/z, scan rate 2.0 spectra/sec, gas temp 225C, gas flow 18 L/min, nebulizer 45 psig, Vcap 3500 V, fragmentor 360 V. Data processed with Profinder B.08 using small molecule chromatographic extraction. |
Ion Mode: | NEGATIVE |